Trends in the treatment and prevention of keratinocyte carcinoma (non-melanoma skin cancer).

Trends in the treatment and prevention of keratinocyte carcinoma (non-melanoma skin cancer).

Curr Opin Pharmacol. 2019 Jan 17;46:19-23

Authors: Zink A

Abstract
Keratinocyte carcinoma (KC), previously also known as non-melanoma skin cancer, is the most common malignancy worldwide. It comprises basal cell carcinoma, squamous cell carcinoma (SCC), and actinic keratoses as carcinoma in situ or precursors of SCC. With solar ultraviolet radiation being the main risk factor, several countries have accepted KC as an occupational disease of outdoor professions. The prevalence in these high-risk groups is substantial, but awareness and preventive behavior remains inadequate. Parallel to the development of improved treatments, such as daylight photodynamic therapy and PD1 inhibitors for progressive KC, target-oriented prevention strategies are requisite if the global burden of KC is to be lowered. Health-related communication, internet search analysis, and telemedicine could be the key to addressing this issue.

PMID: 30660857 [PubMed - as supplied by publisher]